Finecure serves as a contract manufacturing partner across five dedicated blocks - meeting CMO requirements, where production follows an established formula and specification, and full CDMO programmes, where the molecule is developed, scaled, and produced. High-speed automated lines for tablets, capsules, liquids, and injectables, with GS1-compliant serialisation, handle multi-million-unit orders. For partners entering regulated territories, oral solid dosage manufacture is carried out at a USFDA-inspected OSD site, with EIR issued and the cephalosporin injectable plant is PIC/S-approved. Partner intellectual property is protected end to end: Finecure is a SMETA-registered, DSIR-approved manufacturer governed by 21 CFR Part 11 data integrity.
Dedicated oral solid dosage blocks; a 100% physically isolated Clavulanic block with independent HVAC; and a dedicated, PIC/S-approved cephalosporin injectable plant, segregated under GMP as cephalosporin manufacture requires.
Our DSIR-approved R&D centre handles the full lifecycle: pre-formulation, formulation development, and tech-transfer to commercial scale.
High-speed automated lines for tablets, capsules, liquids, and injectables, handling multi-million-unit orders with GS1-compliant serialisation.